Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2

Sponsor Class

OTHER 4FED 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 2

Interventions

pembrolizumab 3enzalutamide 2Testosterone 2Itraconazole 2Exercise 2zanubrutinib 1venetoclax 1stenoparib 1relugolix 1olaparib 1nilutamide 1ibrutinib 1histrelin 1capivasertib 1bicalutamide 1apalutamide 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1acalabrutinib 1abiraterone 1Waiting Lists 1Triptorelin Pamoate 1Temozolomide 1Surveys and Questionnaires 1Radiosurgery 1Prednisone 1Pluvicto 1PM 01183 1Nutritional Status 1Nivolumab 1Methylprednisolone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × FED × Testosterone × Clear all
NCT06084338 2025-12-31

Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc

VA Office of Research and Development

Phase 2 Recruiting
60 enrolled
Genitourinary

Prostatic Neoplasms

NCT05011383 2025-07-09

VA-BAT

VA Office of Research and Development

Phase 2 Recruiting
51 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡